Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in global cord blood corporation of class action lawsuit and upcoming deadlines – corbf

New york, june 05, 2024 (globe newswire) -- pomerantz llp announces that a class action lawsuit has been filed against global cord blood corporation (“global cord” or the “company”) (otc: corbf) and certain officers.   the class action, filed in the united states district court for the southern district of new york, and docketed under 24-cv-03071, is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired global cord securities between june 4, 2019 and may 3, 2022, both dates inclusive (the “class period”), seeking to recover damages caused by defendants' violations of the federal securities laws and to pursue remedies under sections 10(b) and 20(a) of the securities exchange act of 1934 (the “exchange act”) and rule 10b-5 promulgated thereunder, against the company and certain of its top officials.
CO Ratings Summary
CO Quant Ranking